NASDAQ:CASM - CAS Medical Systems Stock Price, Price Target & More

Get Started

$1.59 0.00 (0.00 %)

(As of 05/27/2018 04:00 PM ET)

Previous Close$1.59

Today's Range$1.5501 - $1.59

52-Week Range$0.59 - $1.70

Volume46,716 shs

Average Volume170,455 shs

Market Capitalization$45.65 million

P/E RatioN/A

Dividend YieldN/A

Beta-0.56

About CAS Medical Systems (NASDAQ:CASM)

CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations. The company also offers repair services for parts. It markets products through its own sales force, distributors, and manufacturers' representatives, as well as through hospitals, surgery centers, and outpatient facilities. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.

Receive CASM News and Ratings via Email

Sign-up to receive the latest news and ratings for CASM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments

Sub-IndustryN/A

SectorMedical

SymbolNASDAQ:CASM

CUSIPN/A

Webwww.casmed.com

Phone203-488-6056

Debt

Debt-to-Equity Ratio-0.34

Current Ratio1.54

Quick Ratio1.38

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$18.76 million

Price / Sales2.43

Cash FlowN/A

Price / CashN/A

Book Value($0.43) per share

Price / Book-3.70

Profitability

EPS (Most Recent Fiscal Year)($0.27)

Net Income$-2,330,000.00

Net Margins-9.72%

Return on EquityN/A

Return on Assets-40.08%

Miscellaneous

Employees76

Outstanding Shares28,710,000

CAS Medical Systems (NASDAQ:CASM) Frequently Asked Questions

What is CAS Medical Systems' stock symbol?

CAS Medical Systems trades on the NASDAQ under the ticker symbol "CASM."

How were CAS Medical Systems' earnings last quarter?

CAS Medical Systems, Inc. (NASDAQ:CASM) announced its quarterly earnings data on Thursday, May, 10th. The medical technology company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.01. The medical technology company earned $5.44 million during the quarter, compared to analyst estimates of $4.85 million. View CAS Medical Systems' Earnings History.

When is CAS Medical Systems' next earnings date?

CAS Medical Systems is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for CAS Medical Systems.

Who are some of CAS Medical Systems' key competitors?

Some companies that are related to CAS Medical Systems include SeaSpine (SPNE), Apollo Endosurgery (APEN), Alphatec (ATEC), Restoration Robotics (HAIR), Sensus Healthcare (SRTS), INVO Bioscience (IVOB), Arch Therapeutics (ARTH), Motus GI (MOTS), Invuity (IVTY), Neovasc (NVCN), SANUWAVE (SNWV), Spectral Medical (EDTXF), iCAD (ICAD), Repro-Med Systems (REPR) and Obalon Therapeutics (OBLN).

Who are CAS Medical Systems' key executives?

CAS Medical Systems' management team includes the folowing people:

Mr. Thomas M. Patton J.D., Chief Exec. Officer, Pres and Director (Age 54)
Mr. Jeffery A. Baird, Chief Financial Officer and Sec. (Age 64)
Mr. John K. Gamelin Ph.D., VP of R&D (Age 53)
Dr. Paul B. Benni Ph.D., Chief Scientific Officer (Age 50)
Susan Carron, Director of Corp. Communications

Has CAS Medical Systems been receiving favorable news coverage?

News articles about CASM stock have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CAS Medical Systems earned a news impact score of 0.08 on Accern's scale. They also assigned media coverage about the medical technology company an impact score of 46.45 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are CAS Medical Systems' major shareholders?

CAS Medical Systems' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Acuta Capital Partners LLC (18.17%). Company insiders that own CAS Medical Systems stock include James E Flynn and John Gamelin. View Institutional Ownership Trends for CAS Medical Systems.

Which major investors are buying CAS Medical Systems stock?

CASM stock was purchased by a variety of institutional investors in the last quarter, including Acuta Capital Partners LLC. View Insider Buying and Selling for CAS Medical Systems.

How do I buy shares of CAS Medical Systems?

Shares of CASM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CAS Medical Systems' stock price today?

One share of CASM stock can currently be purchased for approximately $1.59.

How big of a company is CAS Medical Systems?

CAS Medical Systems has a market capitalization of $45.65 million and generates $18.76 million in revenue each year. The medical technology company earns $-2,330,000.00 in net income (profit) each year or ($0.27) on an earnings per share basis. CAS Medical Systems employs 76 workers across the globe.

How can I contact CAS Medical Systems?

CAS Medical Systems' mailing address is 44 East Industrial Road, Branford CT, 06405. The medical technology company can be reached via phone at 203-488-6056 or via email at [email protected]

MarketBeat Community Rating for CAS Medical Systems (CASM)

Community Ranking:		2.6 out of 5 ( )
Outperform Votes:		72 (Vote Outperform)
Underperform Votes:		65 (Vote Underperform)
Total Votes:		137

MarketBeat's community ratings are surveys of what our community members think about CAS Medical Systems and other stocks. Vote "Outperform" if you believe CASM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CASM will underperform the S&P 500 over the long term. You may vote once every thirty days.

CAS Medical Systems (NASDAQ:CASM) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details

(Data available from 5/27/2016 forward)

CAS Medical Systems (NASDAQ:CASM) Earnings History and Estimates Chart

Earnings by Quarter for CAS Medical Systems (NASDAQ:CASM)

CAS Medical Systems (NASDAQ:CASM) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.26 EPS
Next Year EPS Consensus Estimate: $-0.13 EPS

CAS Medical Systems (NASDAQ CASM) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/6/2018							N/A
5/10/2018	Q1 2018	($0.08)	($0.07)	$4.85 million	$5.44 million	View	N/A
3/14/2018	Q4 2017	($0.07)	($0.0720)	$4.96 million	$5.12 million	View	Listen
11/9/2017	Q3 2017	($0.06)	($0.01)	$4.47 million	$4.53 million	View	N/A
8/8/2017	Q2 2017	($0.07)	($0.09)	$5.41 million	$4.57 million	View	Listen
5/3/2017	Q1 2017	($0.06)	($0.08)	$5.73 million	$5.23 million	View	Listen
3/9/2017	Q4 2016	($0.03)	($0.0670)	$5.49 million	$5.48 million	View	Listen
11/8/2016	Q3	($0.05)	($0.06)	$5.85 million	$5.76 million	View	Listen
8/4/2016	Q2	($0.05)	($0.08)	$5.58 million	$5.50 million	View	N/A
5/5/2016	Q1	($0.06)	($0.03)	$5.88 million	$5.46 million	View	N/A
3/9/2016	Q4	($0.07)	($0.08)	$5.20 million	$5.80 million	View	Listen
11/5/2015	Q315	($0.09)	($0.08)	$5.66 million	$5.50 million	View	N/A
8/5/2015	Q215	($0.10)	($0.09)	$5.36 million	$5.80 million	View	N/A
5/5/2015	Q115	($0.10)	($0.08)	$5.21 million	$5.80 million	View	N/A
3/4/2015	Q414	($0.11)	($0.11)	$5.80 million	$5.80 million	View	N/A
11/4/2014	Q3 2014	($0.12)	($0.10)		$5.53 million	View	N/A
8/6/2014	Q214	($0.11)	($0.11)	$5.00 million	$5.80 million	View	N/A
5/1/2014	Q1 2014	($0.13)	($0.11)		$5.71 million	View	N/A
3/6/2014	Q413	($0.17)	($0.19)	$5.90 million	$5.90 million	View	N/A
11/12/2013	Q3		($0.19)	$6.10 million	$5.40 million	View	Listen
8/7/2013	Q2 2013		($0.22)	$5.20 million	$5.00 million	View	N/A
5/8/2013	Q1 2013		($0.14)		$5.58 million	View	N/A
3/7/2013	Q4 2012		($0.18)			View	N/A
11/8/2012	Q312		($0.14)	$5.79 million	$6.11 million	View	N/A
8/8/2012	Q2 2012		($0.15)			View	N/A
5/8/2012	Q1 2012		($0.17)			View	N/A
3/6/2012	Q4 2011		($0.15)			View	N/A
11/8/2011	Q3 2011		($0.16)			View	N/A
8/10/2011	Q2 2011		($0.12)			View	N/A
5/11/2011	Q1 2011		($0.10)			View	N/A
3/2/2011	Q4 2010		($0.06)			View	N/A
11/11/2010	Q3 2010		($0.04)			View	N/A
5/5/2010	Q1 2010		$0.02			View	N/A
3/3/2010	Q4 2009		($0.38)			View	N/A
11/5/2009	Q3 2009		$0.02			View	N/A
8/5/2009	Q2 2009		($0.07)			View	N/A
5/6/2009	Q1 2009		($0.08)			View	N/A
2/25/2009	Q4 2008		($0.01)			View	N/A
11/6/2008	Q3 2008		$0.03			View	N/A
5/1/2008	Q1 2008		($0.05)			View	N/A

(Earnings results data provided by Zacks Investment Research)

CAS Medical Systems (NASDAQ:CASM) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

CAS Medical Systems (NASDAQ CASM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 37.60%
Institutional Ownership Percentage: 22.72%

Insider Trading History for CAS Medical Systems (NASDAQ:CASM)

Institutional Ownership by Quarter for CAS Medical Systems (NASDAQ:CASM)

CAS Medical Systems (NASDAQ CASM) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/16/2018	John Gamelin	VP	Sell	3,000	$1.37	$4,110.00	180,078
5/14/2018	John Gamelin	VP	Sell	2,000	$1.36	$2,720.00	180,078
3/15/2018	John Gamelin	VP	Sell	3,000	$1.16	$3,480.00	183,578
1/26/2017	James E Flynn	Insider	Sell	636,238	$1.46	$928,907.48
1/23/2017	James E Flynn	Insider	Sell	205,126	$1.53	$313,842.78
5/15/2015	Brian J Wagner	Insider	Buy	2,032	$1.31	$2,661.92
2/11/2015	Thomas M Patton	CEO	Buy	40,000	$1.30	$52,000.00
2/11/2015	Thomas, Mcnerney & Partners Ii	Major Shareholder	Buy	1,605,000	$1.30	$2,086,500.00
9/2/2014	Thomas M Patton	CEO	Buy	1,500	$1.48	$2,220.00
8/18/2014	Thomas M Patton	CEO	Buy	10,000	$1.54	$15,400.00
8/8/2014	Thomas M Patton	CEO	Buy	10,000	$1.61	$16,100.00
8/21/2013	Thomas M Patton	CEO	Buy	5,300	$1.42	$7,526.00
9/6/2012	Thomas M Patton	CEO	Buy	10,332	$1.88	$19,424.16

(Data available from 1/1/2013 forward)

CAS Medical Systems (NASDAQ CASM) News Headlines

Source:

Date	Headline
	Zacks Investment Research Equities Analysts Boost Earnings Estimates for CAS Medical Systems, Inc. (CASM) www.americanbankingnews.com - May 18 at 8:22 AM
	CAS Medical Systems (CASM) Upgraded at ValuEngine www.americanbankingnews.com - May 17 at 10:56 PM
	FDA Clears CASMED’s FORE-SIGHT Tissue Oximetry OEM Module finance.yahoo.com - May 16 at 10:18 AM
	CASM: Q1: FORE-SIGHT Revenue Jumps 20% in Q1. Sensors Sales Accelerating. Moving PT to $4.00/share finance.yahoo.com - May 16 at 10:18 AM
	CAS Medical Systems' (CASM) CEO Tom Patton on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - May 12 at 10:43 AM
	CAS Medical Systems (CASM) Posts Earnings Results www.americanbankingnews.com - May 11 at 4:17 PM
	CASMED Reports First-Quarter 2018 Financial Results finance.yahoo.com - May 11 at 11:02 AM
	Edited Transcript of CASM earnings conference call or presentation 10-May-18 2:00pm GMT finance.yahoo.com - May 11 at 11:02 AM
	CAS Medical Systems (CASM) Upgraded to Hold at ValuEngine www.americanbankingnews.com - May 7 at 11:10 PM
	CASMED to Report First-Quarter 2018 Financial Results and Hold Conference Call on May 10 finance.yahoo.com - May 3 at 9:49 AM
	CAS Medical Systems, Inc. (CASM) Major Shareholder Acquires $10,341.10 in Stock www.americanbankingnews.com - May 1 at 8:16 PM
	Acuta Capital Fund, Lp Purchases 17,643 Shares of CAS Medical Systems, Inc. (CASM) Stock www.americanbankingnews.com - May 1 at 8:16 PM
	CAS Medical Systems, Inc. (CASM) Major Shareholder Buys $27,850.59 in Stock www.americanbankingnews.com - May 1 at 8:16 PM
	CAS Medical Systems, Inc. (CASM) Major Shareholder Buys $24,437.50 in Stock www.americanbankingnews.com - May 1 at 8:16 PM
	Insider Buying: CAS Medical Systems, Inc. (CASM) Major Shareholder Acquires 37,520 Shares of Stock www.americanbankingnews.com - May 1 at 7:52 PM
	Acuta Capital Fund, Lp Buys 28,476 Shares of CAS Medical Systems, Inc. (CASM) Stock www.americanbankingnews.com - May 1 at 7:52 PM
	CAS Medical Systems (CASM) Set to Announce Quarterly Earnings on Tuesday www.americanbankingnews.com - April 24 at 8:24 AM
	CAS Medical Systems (CASM) Upgraded to Sell by ValuEngine www.americanbankingnews.com - April 3 at 6:26 PM
	CASM: Q4 2017 Financial Results: Record Revenue, Lowest Op Loss. Momentum Expected to Continue finance.yahoo.com - March 27 at 10:28 AM
	CAS Medical Systems (CASM) Raised to "Sell" at ValuEngine www.americanbankingnews.com - March 25 at 8:10 PM
	Edited Transcript of CASM earnings conference call or presentation 14-Mar-18 2:00pm GMT finance.yahoo.com - March 18 at 9:56 AM
	CAS Medical Systems, Inc. to Host Earnings Call www.baystreet.ca - March 14 at 11:15 AM
	CAS Medical Systems revenues up 11% in Q4 seekingalpha.com - March 14 at 11:15 AM
	CASMED Reports 2017 Fourth-Quarter and Full-Year Financial Results finance.yahoo.com - March 14 at 11:15 AM
	CASMED to Report Fourth-Quarter and 2017 Full-Year Financial Results and Hold Conference Call on March 14 finance.yahoo.com - March 7 at 10:13 AM
	CAS Medical Systems (CASM) Downgraded by ValuEngine www.americanbankingnews.com - March 4 at 10:00 PM
	CAS Medical Systems (CASM) Scheduled to Post Earnings on Wednesday www.americanbankingnews.com - February 28 at 1:24 AM
	What does CAS Medical Systems Inc’s (NASDAQ:CASM) Balance Sheet Tell Us About Its Future? finance.yahoo.com - February 27 at 4:35 PM
	BRIEF-Cas Medical Systems Says Expects To Receive Regulatory Clearance For OEM Module In Q2 2018 www.reuters.com - January 25 at 8:44 AM
	CASMED Submits FORE-SIGHT® OEM Module 510(k) to FDA finance.yahoo.com - January 24 at 9:08 AM
	Catalyst OrthoScience Strengthens Its Board of Directors with The Addition of Greg Rainey www.prnewswire.com - January 17 at 9:43 AM
	CASMED Reports Preliminary Net Sales for the 2017 Fourth Quarter finance.yahoo.com - January 4 at 9:48 AM
	ETFs with exposure to CAS Medical Systems, Inc. : December 7, 2017 finance.yahoo.com - December 7 at 5:23 PM
	CAS Medical Systems, Inc. :CASM-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017 finance.yahoo.com - December 5 at 10:32 AM
	BRIEF-‍Long Focus Capital Management Reports 6.9 Pct Passive Stake In CAS Medical Systems www.reuters.com - December 3 at 9:52 AM
	CASMED to Present at the LD Micro Main Event Conference finance.yahoo.com - November 29 at 9:57 AM
	FY2017 Earnings Forecast for CAS Medical Systems, Inc. Issued By Zacks Investment Research (CASM) www.americanbankingnews.com - November 22 at 6:44 AM
	CASM: Operational Successes Bode Well For Restarting Sensors Sales Growth finance.yahoo.com - November 20 at 6:05 PM
	Edited Transcript of CASM earnings conference call or presentation 9-Nov-17 3:00pm GMT finance.yahoo.com - November 19 at 2:47 AM
	CAS Medical Systems, Inc. (CASM) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS www.americanbankingnews.com - November 10 at 12:51 PM
	CASMED Reports Third-Quarter 2017 Financial Results finance.yahoo.com - November 9 at 6:46 PM
	Should Your Next Investment In The Healthcare Industry Be In CAS Medical Systems Inc (CASM)? finance.yahoo.com - November 9 at 6:46 PM
	ETFs with exposure to CAS Medical Systems, Inc. : November 9, 2017 finance.yahoo.com - November 9 at 6:46 PM
	CASMED to Report Third-Quarter 2017 Financial Results and Hold Conference Call on November 9 finance.yahoo.com - November 2 at 5:39 PM
	How Financially Strong Is CAS Medical Systems Inc (CASM)? finance.yahoo.com - October 31 at 11:07 PM
	CAS Medical Systems, Inc. (CASM) Set to Announce Quarterly Earnings on Monday www.americanbankingnews.com - October 30 at 8:50 AM
	ETFs with exposure to CAS Medical Systems, Inc. : October 27, 2017 finance.yahoo.com - October 27 at 7:29 PM
	Edited Transcript of CASM earnings conference call or presentation 9-Mar-17 3:00pm GMT finance.yahoo.com - October 18 at 6:14 PM
	Edited Transcript of CASM earnings conference call or presentation 3-May-17 2:00pm GMT finance.yahoo.com - October 17 at 5:43 PM
	Patient Monitoring Equipment Market 2017 Global Analysis, Opportunities and Forecast to 2022 www.marketwatch.com - October 13 at 10:37 PM

CAS Medical Systems (NASDAQ:CASM) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

CAS Medical Systems (NASDAQ:CASM) Income Statement, Balance Sheet and Cash Flow Statement

CAS Medical Systems (NASDAQ CASM) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff